RECRUITING

NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is a double-blind, randomized controlled trial comparing the effectiveness of oral acetaminophen, diclofenac, and tramadol in reducing the consumption of narcotic doses (primary outcome) and minimizing patients' exposure to narcotics (secondary outcome) following an ultrasound-guided percutaneous needle tenotomy procedure on the lateral elbow.

Official Title

A Randomized Controlled Trial: Alternative Post Procedural Analgesia With NSAIDs vs Opioids in Percutaneous Needle Tenotomy of Elbow

Quick Facts

Study Start:2024-08-12
Study Completion:2025-12-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06373978

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Provision of signed and dated informed consent form
  2. * Stated willingness to comply with all study procedures and availability for the duration of the study
  3. * Male or female, aged 18-65 years
  4. * Percutaneous Needle Tenotomy of Lateral Elbow Procedure
  5. * Ability to take oral medication and willingness to participate in a 2-week follow-up pill counts
  6. * Musculoskeletal ultrasound or MRI with diagnosis of tendinosis of the common extensor tendon of the elbow
  1. * • Any full thickness common extensor tendon tear of the elbow
  2. * Prior history of elbow surgery
  3. * Symptomatic cervical radiculopathy
  4. * Concurrent symptoms of the medial elbow
  5. * Treatment with another investigational drug or other intervention concurrently or previously that would interfere with postoperative pain control
  6. * Psychiatric illness that impedes evaluation of pain and/or narcotics use
  7. * No history of inflammatory arthritis, diabetes, chronic regional pain syndrome, connective tissue disease, fibromyalgia or autoimmune disease
  8. * No contraindications to NSAIDs or Opioids

Contacts and Locations

Study Contact

Jennifer Baldwin
CONTACT
216.390.5833
baldwij@ccf.org
Alison Klika, MS
CONTACT
216 444-4954
klikaa@ccf.org

Principal Investigator

Michael Dakkak, DO
PRINCIPAL_INVESTIGATOR
Cleveland Clinic Florida

Study Locations (Sites)

The Cleveland Clinic Florida
Coral Springs, Florida, 33067
United States
The Cleveland Clinic Ohio
Avon, Ohio, 44011
United States

Collaborators and Investigators

Sponsor: The Cleveland Clinic

  • Michael Dakkak, DO, PRINCIPAL_INVESTIGATOR, Cleveland Clinic Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-12
Study Completion Date2025-12-15

Study Record Updates

Study Start Date2024-08-12
Study Completion Date2025-12-15

Terms related to this study

Keywords Provided by Researchers

  • TenJet
  • Elbow

Additional Relevant MeSH Terms

  • Elbow Pain
  • Chronic Pain